NEW YORK (AP) — NEW YORK (AP) — Actinium Pharmaceuticals Inc. (ATNM) on Friday reported a loss of $5.1 million in its third quarter.
On a per-share basis, the New York-based company said it had a loss of 16 cents.
The cancer drug developer posted revenue of $90,000 in the period.
In the final minutes of trading on Friday, the company's shares hit $1.27. A year ago, they were trading at $1.65.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNM at https://www.zacks.com/ap/ATNM
